20Med Therapeutics

Company profile

20Med Therapeutics company profile

20Med Therapeutics is a Dutch biomedical company active in the field of controlled drug delivery, developing and exploiting a portfolio of multifunctional polymer-based carriers for targeted delivery of small interfering RNAs (siRNAs) and microRNAs (miRNAs) for treatment of genetic diseases. The 20Med delivery technology is based on the development of a unique set of polymeric hybrid constructs (hereafter called 20Med-nanogels) which possess an unmet combination of properties essential for successful siRNA delivery in clinical applications. 20Med-nanogels are stable, well-processable, nontoxic and biodegradable nanoparticles that can be stored as powder formulation and can be easily loaded with oligonucleotides after dissolution. Specific..... For more information, log in to dureach.com to view the full company profile.